Pharmacotherapy Case Study 7: Nausea and Vomiting By: Dr. Nehad Ahmed
Pharmacotherapy
Case Study 7: Nausea and Vomiting By: Dr. Nehad Ahmed
Chief
Complaint:
A
45-year-old male presents with a 3-day history of persistent nausea and
vomiting. He reports feeling nauseous throughout the day, with frequent
episodes of vomiting, primarily in the morning.
Subjective
Data:
History
of Present Illness (HPI):
·
The patient states that for the past 3 days, he
has been experiencing constant nausea, which is worse in the morning, often
leading to vomiting. Vomiting consists of food and bile, with no blood or
coffee-ground appearance.
·
He reports a lack of appetite, which has
contributed to mild weight loss of approximately 4 pounds over the past 3 days.
·
The nausea is accompanied by mild abdominal
discomfort but no significant pain. He describes the abdominal discomfort as a
feeling of fullness and bloating.
·
He has not been able to keep much food or fluid
down, which has led to some dehydration symptoms, including dry mouth and
dark-colored urine.
·
No history of diarrhea, fever, or chills. He
denies any recent trauma or travel history.
·
The patient is concerned that the nausea and
vomiting are related to an illness or the stress at work, as he has been
dealing with increased workload pressures recently.
·
He denies alcohol use, smoking, or illicit drug
use.
Past
Medical History (PMH):
·
Hypertension: Diagnosed 3 years ago, well-controlled on
medication.
·
Gastroesophageal reflux disease (GERD): Diagnosed 5
years ago, managed with omeprazole 20 mg daily.
·
No history of gastrointestinal surgeries, malignancy,
or chronic conditions besides hypertension.
Medications:
·
Omeprazole 20 mg orally once
daily for GERD.
·
Lisinopril 10 mg orally once
daily for hypertension.
·
Acetaminophen 500 mg as needed for
headaches.
Allergies:
·
No known drug allergies (NKDA).
Social
History:
·
Non-smoker.
·
Occasional alcohol use (1-2 drinks per week).
·
Works as a project manager with high stress and
long hours.
·
No significant recent changes in diet, except
for increased consumption of caffeine due to work demands.
Family
History:
·
Father with a history of type 2 diabetes
and hypertension.
·
Mother with a history of gallbladder disease
(cholecystectomy at age 50).
·
No family history of gastrointestinal cancers
or chronic GI disorders.
Review
of Systems (ROS):
·
Gastrointestinal: Persistent
nausea, vomiting (no blood), mild abdominal discomfort. Denies diarrhea,
constipation, or recent changes in bowel habits.
·
Cardiovascular: No chest
pain, palpitations, or edema.
·
Respiratory: No shortness of breath or cough.
·
Neurological: No dizziness, headaches, or visual changes.
·
Musculoskeletal: No
significant muscle or joint pain.
Objective
Data:
Vital
Signs:
·
Blood Pressure: 120/78 mmHg
·
Heart Rate: 88 bpm
·
Respiratory Rate: 16 breaths/min
·
Temperature: 98.4°F (36.9°C)
·
Weight: 185 lbs (83.9 kg) (4 lbs weight loss in
the past 3 days)
·
Height: 5'10" (178 cm)
Physical
Exam:
·
General: Alert and oriented, appears fatigued but not
in acute distress. Mild dry mucous membranes noted.
·
Abdomen: Soft, non-distended. Mild epigastric
tenderness on palpation. No rebound tenderness or guarding. Bowel sounds are
normal.
·
Cardiovascular: Regular rate
and rhythm, no murmurs or gallops.
·
Respiratory: Clear to auscultation bilaterally.
·
Neurological: Alert and oriented with no focal deficits.
·
Skin: Dry, no rashes or signs of jaundice.
Labs
and Imaging:
·
Complete Blood Count (CBC):
o Hemoglobin:
14.2 g/dL (normal)
o Hematocrit: 41%
(normal)
o White Blood
Cell Count: 6,500/mm³ (normal)
o Platelets: 220,000/mm³
(normal)
·
Basic Metabolic Panel (BMP):
o Sodium: 138
mEq/L (normal)
o Potassium: 3.9
mEq/L (normal)
o Chloride: 101
mEq/L (normal)
o Bicarbonate: 23
mEq/L (normal)
o Blood Urea
Nitrogen (BUN): 16 mg/dL (normal)
o Creatinine: 0.9
mg/dL (normal)
o Glucose: 98
mg/dL (normal)
·
Liver Function Tests (LFTs):
o Alanine
aminotransferase (ALT): 25 U/L (normal)
o Aspartate
aminotransferase (AST): 22 U/L (normal)
o Total
bilirubin: 0.4 mg/dL (normal)
·
Urinalysis:
o Specific
gravity: 1.030 (slightly concentrated, suggestive of mild dehydration)
o No protein,
glucose, or blood detected.
·
Abdominal Ultrasound: No evidence
of gallstones, liver, or pancreatic abnormalities. Normal findings.
·
Electrocardiogram (ECG): Normal sinus
rhythm.
Assessment:
The
patient is presenting with acute nausea and vomiting of unclear
etiology, with associated mild dehydration, weight loss, and epigastric
discomfort. The differential diagnosis includes:
·
Gastritis or peptic ulcer disease: Given the
patient's history of GERD and epigastric tenderness, these could be
contributing factors, although no overt gastrointestinal bleeding is present.
·
Gastroenteritis: Less likely
given the lack of fever and diarrhea.
·
Medication side effects: Although the
patient is on omeprazole, nausea and vomiting are not common side effects.
However, overuse or misuse of NSAIDs, though not currently reported, could be a
factor.
·
Stress-related nausea: Increased
stress and lack of appetite could be contributing to his symptoms.
·
Gallbladder disease: The patient's
family history of gallbladder disease raises the possibility of biliary issues,
but ultrasound findings are normal.
·
Peptic ulcer disease: Could be
considered given the patient's history of GERD, but no severe symptoms of
bleeding or perforation are present.
Plan:
Pharmacologic
Treatment:
1.
Antiemetic Therapy:
o Ondansetron
4 mg orally every 8 hours as needed for nausea.
2.
Antacid Therapy:
o Ranitidine
150 mg orally twice daily (H2 blocker) to help manage potential
gastritis or reflux contributing to nausea.
3.
Rehydration:
o Encourage oral
rehydration solutions (ORS) for fluid replacement due to dehydration. If
vomiting persists, consider IV fluids.
4.
Proton Pump Inhibitor (PPI):
o Continue omeprazole
20 mg daily for GERD, but ensure patient is adhering to the medication as
prescribed.
Non-Pharmacologic
Treatment:
·
Dietary modifications: Recommend a
bland, low-fat diet to minimize irritation to the stomach. Avoid spicy or
acidic foods.
·
Hydration: Encourage adequate fluid intake, particularly
water and oral rehydration solutions to combat dehydration.
·
Stress management: Suggest
relaxation techniques such as deep breathing exercises, meditation, or
mindfulness practices.
Monitoring
and Follow-Up:
·
Follow-up in 2-3 days to evaluate
symptom control and fluid intake. If vomiting continues or worsens, consider
further diagnostic testing (e.g., upper GI endoscopy).
·
If symptoms do not improve or if there is
evidence of a more serious condition (e.g., worsening pain, signs of GI
bleeding), further investigation may include endoscopy, CT abdomen,
or referral to a gastroenterologist.
Patient
Education:
·
Educate the patient on the importance of
maintaining hydration and eating small, frequent meals to manage nausea.
·
Explain the possible side effects of
ondansetron and ranitidine (e.g., constipation, dizziness) and advise the
patient to contact healthcare providers if any new symptoms arise.
·
Discuss stress management techniques and the
potential impact of stress on gastrointestinal health.
Referral:
·
If symptoms persist or worsen, referral to a gastroenterologist
for further evaluation may be warranted, particularly if peptic ulcer disease
or other GI disorders are suspected.
Long-Term
Management:
·
If the cause is determined to be stress or
anxiety-related, further management with counseling or stress management
techniques may be beneficial.
تعليقات
إرسال تعليق